Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
-
SciScore for 10.1101/2021.02.18.431825: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Data collection and Processing: Transcriptomics and protein abundance data from COVID-19 patient’s naso- and oropharyngeal swab, bronchoalveolar lavage fluid (BALF), and other respiratory specimens were chosen from PubMed, BioRxiv, and MedRxiv using different combinations of keywords like “COVID-19, SARS-CoV-2 PubMedsuggested: (PubMed, RRID:SCR_004846)BioRxivsuggested: (bioRxiv, RRID:SCR_003933)The SARS-CoV-2 and COVID-19 collections in the EMBL-EBI PRIDE proteomics database (20) … SciScore for 10.1101/2021.02.18.431825: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Data collection and Processing: Transcriptomics and protein abundance data from COVID-19 patient’s naso- and oropharyngeal swab, bronchoalveolar lavage fluid (BALF), and other respiratory specimens were chosen from PubMed, BioRxiv, and MedRxiv using different combinations of keywords like “COVID-19, SARS-CoV-2 PubMedsuggested: (PubMed, RRID:SCR_004846)BioRxivsuggested: (bioRxiv, RRID:SCR_003933)The SARS-CoV-2 and COVID-19 collections in the EMBL-EBI PRIDE proteomics database (20) were retrieved and used without any modification. PRIDEsuggested: (Pride-asap, RRID:SCR_012052)In the NCBI GEO database (21) the following combination of terms was used to collect relevant datasets: ((covid-19 OR SARS-COV-2 NCBI GEOsuggested: NoneGene Ontology, Interferome Analysis, Cellular and tissue localization analysis: Enriched GO terms were obtained by express analysis on Metascape (24) and plotted using ggplot2 (25). Metascapesuggested: (Metascape, RRID:SCR_016620)ggplot2suggested: (ggplot2, RRID:SCR_014601)The single-cell expression data of transcripts was also obtained from Human Protein Atlas ver20.0 (Available from http://www.proteinatlas.org/). http://www.proteinatlas.org/suggested: (HPA, RRID:SCR_006710)Cytoscape v3.8.0 (30) was used to construct the interaction network for virus-host protein-protein interaction. Cytoscapesuggested: (Cytoscape, RRID:SCR_003032)STRING database within the Cytoscape store was used to query the proteins to elucidate the interactions between the proteins significantly altered during SARS-CoV-2 infection. STRINGsuggested: (STRING, RRID:SCR_005223)Statistical analysis: All statistical analyses and overlaps were performed in the R statistical environment version 4.0.3 via RStudio version 1.3.1093. RStudiosuggested: (RStudio, RRID:SCR_000432)Heatmaps were generated using the R package ComplexHeatmap (31). ComplexHeatmapsuggested: (ComplexHeatmap, RRID:SCR_017270)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-